Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: New Zealand Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20211
20221
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Evommune, Inc.2
ASLAN Pharmaceuticals1
Akesobio Australia Pty Ltd1
Botanix Pharmaceuticals1
Inmagene LLC1
MedImmune LLC1
Prana Therapies Inc1
Tavotek Biotherapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic9
Eczema6
Dermatitis1
Immune System Diseases1
Pruritus1
Skin Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.